← Evidence map

ArticleTherapeutic advances in endocrinology and metabolism2026

Teplizumab in stage 2 type 1 diabetes- pediatric considerations, realistic expectations, and the evolving technological landscape.

Hussein ZaitoonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42643804